Veradigm Inc
OTC:MDRX

Watchlist Manager
Veradigm Inc Logo
Veradigm Inc
OTC:MDRX
Watchlist
Price: 4.5 USD
Market Cap: $490.1m

Veradigm Inc
Research & Development

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Veradigm Inc
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Veradigm Inc
OTC:MDRX
Research & Development
-$97.9m
CAGR 3-Years
26%
CAGR 5-Years
14%
CAGR 10-Years
5%
Veeva Systems Inc
NYSE:VEEV
Research & Development
-$750.1m
CAGR 3-Years
-16%
CAGR 5-Years
-22%
CAGR 10-Years
-29%
Inspire Medical Systems Inc
NYSE:INSP
Research & Development
-$103.2m
CAGR 3-Years
-15%
CAGR 5-Years
-32%
CAGR 10-Years
N/A
Doximity Inc
NYSE:DOCS
Research & Development
-$93m
CAGR 3-Years
-14%
CAGR 5-Years
-23%
CAGR 10-Years
N/A
Omnicell Inc
NASDAQ:OMCL
Research & Development
-$88.7m
CAGR 3-Years
4%
CAGR 5-Years
-6%
CAGR 10-Years
-10%
W
Waystar Holding Corp
NASDAQ:WAY
Research & Development
-$54.6m
CAGR 3-Years
-19%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Veradigm Inc
Glance View

Market Cap
490.1m USD
Industry
Health Care

Veradigm Inc., formerly known as Allscripts Healthcare Solutions, has carved out a distinct niche within the healthcare technology landscape. The company focuses on the dynamic intersection of technology and healthcare, developing an array of solutions aimed at enhancing healthcare delivery and efficiency. Essentially, Veradigm equips medical professionals with tools for electronic health records, practice management, and remote patient monitoring. By leveraging sophisticated information systems, Veradigm helps streamline operations in doctor's offices, hospitals, and healthcare organizations, making it easier for healthcare providers to deliver efficient and effective services. Their products are designed not only to improve clinical workflows but also to enhance patient engagement, ultimately leading to better health outcomes. The revenue model of Veradigm hinges largely on contractual agreements and subscriptions for its software solutions. By offering a range of cloud-based services, the company ensures a steady flow of recurrent income while reducing the need for expensive on-site installations, thus delivering value to both large hospital systems and smaller, private practices. Additionally, Veradigm has diversified its revenue streams through collaborations with pharmaceutical companies, providing data insights and support for research and marketing initiatives. With a persistent focus on innovation and adaptability, Veradigm not only strengthens its foundational business in healthcare IT but also taps into new opportunities within the emerging landscape of digital health and data analytics.

MDRX Intrinsic Value
Not Available

See Also

What is Veradigm Inc's Research & Development?
Research & Development
-97.9m USD

Based on the financial report for Dec 31, 2022, Veradigm Inc's Research & Development amounts to -97.9m USD.

What is Veradigm Inc's Research & Development growth rate?
Research & Development CAGR 10Y
5%

Over the last year, the Research & Development growth was 49%. The average annual Research & Development growth rates for Veradigm Inc have been 26% over the past three years , 14% over the past five years , and 5% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett